Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) traded up 21.2% during mid-day trading on Thursday . The company traded as high as C$0.20 and last traded at C$0.20. 216,394 shares changed hands during trading, a decline of 60% from the average session volume of 534,659 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Price Performance
The company’s 50 day simple moving average is C$0.11 and its 200 day simple moving average is C$0.08. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The stock has a market capitalization of C$25.10 million, a PE ratio of -18.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- The How And Why of Investing in Oil Stocks
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- 3 Best Fintech Stocks for a Portfolio Boost
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- How to invest in marijuana stocks in 7 steps
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
